Enrique García-Rivera is VP of Data Science at Formation Bio, where he leads a function building AI systems that predict clinical trial outcomes, identify drug investment opportunities, and drive precision medicine strategies across the company's therapeutic portfolio. His team connects molecular and real-world clinical evidence through causal inference and multi-modal data integration to inform both drug development and investment decisions. He has over a decade of experience applying machine learning and AI to drug discovery and clinical development, with prior roles at BullFrog AI, ROME Therapeutics, nference, and the Broad Institute. Enrique holds a PhD in Biological and Biomedical Sciences from Harvard Medical School and a BSc in Interdisciplinary Sciences from the University of Puerto Rico.